Explorer

US-Based Pharma Gilead To Help Expand Availability Of Remdesivir In India

“We are committed to doing our part to help tackle this crisis. Our immediate focus is to help address the needs of patients in India who may benefit from remdesivir as quickly as we can by working together with the government, health authorities and our voluntary licensees,” Johanna Mercier, chief commercial officer of Gilead Sciences said on Monday.

New Delhi: On Monday, Gilead announced the steps it is going to take to help expand avvailability of Remdesivir a drugs which is essential in the treatment of Covid-19 in India. 

The company announced that it was providing its voluntary licensing partners technical assistance, support for addition of new local manufacturing facilities and donation of active pharmaceutical ingredient (API) to rapidly scale up the production of remdesivir.

ALSO READ: DGCA Extends Price Capping On Domestic Flights, Seating Operations To Continue At 80%

“The recent surge of COVID-19 cases in India is having a devastating impact on communities and has created unprecedented pressure on health systems,” Johanna Mercier, chief commercial officer of Gilead Sciences said on Monday.

While its efficacy is heavily debated interantionally, India has approved the restricted emergency use of Remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe disease.

Gilead in addition will donate at least 450,000 vials of Veklury (remdesivir) to help address the immediate needs of Indian patients, the company said.

“We are committed to doing our part to help tackle this crisis. Our immediate focus is to help address the needs of patients in India who may benefit from remdesivir as quickly as we can by working together with the government, health authorities and our voluntary licensees,” Mercier said according to PTI.

All seven of Gilead’s licensees based in India have significantly accelerated production of remdesivir by scaling up their batch sizes, adding new manufacturing facilities and/or onboarding local contract manufacturers across the country, it said.

Gilead’s voluntary licensing program for remdesivir, established in May 2020, has already enabled access to the drug for more than 2.3 million people in more than 60 low and middle-income countries.

View More
Advertisement
IOI
Don't Miss Out
48
Hours
25
Minutes
32
Seconds
Advertisement
Wed Feb 19, 9:04 am
connaught place
26.3°
Precipitation: 0 mm    Humidity: 31%   Wind: WSW 11.7 km/h
See Today's Weather
Powered By:
Accu Weather
Advertisement

Top Headlines

Another Fire At Maha Kumbh — Bike Erupts In Flames Amid Traffic Jam In Prayagraj
Another Fire At Maha Kumbh — Bike Erupts In Flames Amid Traffic Jam In Prayagraj
PAK vs NZ, Champions Trophy 2025: Pakistan Win Toss & Choose To Bowl First In Karachi, Check Out Playing 11s
PAK vs NZ, Champions Trophy 2025: Pakistan Win Toss & Choose To Bowl First In Karachi, Check Out Playing 11s
Udhayanidhi Stalin Slams BJP Over Fund Refusal: 'Not Asking For Your Father's Money'
Udhayanidhi Stalin Slams BJP Over Fund Refusal: 'Not Asking For Your Father's Money'
YSRCP Alleges Severe Lapses In Security For Former CM YS Jagan Mohan Reddy: 'Police Showed Complete Negligence'
YSRCP Alleges Severe Lapses In Security For Former CM YS Jagan Mohan Reddy: 'Police Showed Complete Negligence'
Advertisement
ABP Premium

Videos

Breaking News: Delhi CM Race Intensifies as BJP Preps for Oath-Taking with Tight Security | ABP NEWSDelhi CM Race: BJP May Pick Purvanchali Leader, Final Decision in Today’s MeetingDelhi CM Race: Preference for RSS-Backed Leader, Ashish Sood Leading ContenderBreaking News: BJP to Honor Delhi's Slum Leaders at Oath-Taking Ceremony After Historic Win | ABP NEWS

Photo Gallery

Embed widget

We use cookies to improve your experience, analyze traffic, and personalize content. By clicking "Allow All Cookies", you agree to our use of cookies.